Estimated read time: Less than a minute
This archived news story is available only for your personal, non-commercial use. Information in the story may be outdated or superseded by additional information. Reading or replaying the story in its archived form does not constitute a republication of the story.
Dr. Kim Mulvihill ReportingThere's a warning out today from the FDA about the new meningitis vaccine. Doctors and patients are being alerted to reports of a rare brain disorder associated with Menactra.
Five teenagers have come down with Guillain Barre syndrome two to four weeks after getting the vaccine. Right now officials do not know if these cases were caused by the vaccine, or if it was just coincidence.
The rate of these cases is similar to what is normally expected. However, officials say the timing of these five cases is of concern.
The FDA is still recommending vaccination for middle and high school students, as well as college freshman living in dorms.
Guillain Barre syndrome causes increasing weakness in the legs and arms, but in most cases patients recover completely.
More than 2 point 5 million doses of Menactra have been issued.